title: Coordinate and divergent regulation of corticotropin-releasing factor (CRF) and CRF-binding protein expression in an immortalized amygdalar neuronal cell line.
abstract: CRF is a 41-amino acid neuropeptide best known for its hypophysiotropic actions. CRF is widely distributed in the central nervous system in areas beyond the hypothalamus. CRF-binding protein (CRF-BP) regulates the bioavailability of CRF, and knowledge of the regulation of CRF-BP synthesis is an integral component of understanding the actions of CRF. To better study the regulation of CRF and CRF-BP, primary amygdalar cultures were immortalized by transfection with the SV 40 large T antigen. A clonal line that expresses CRF immunoreactivity and messenger RNA was selected. The production of CRF peptide and message by this line is regulated in a manner indistinguishable from primary cultures. We also observed that the immortalized cells express CRF-BP immunoreactivity and messenger RNA. The expression of both CRF and CRF-BP is positively regulated by forskolin and interleukin-6. Unlike CRF, the expression of CRF-BP message and peptide was increased by phorbol 12-myristate 13-acetate or dexamethasone. These results demonstrate that the synthesis of CRF and CRF-BP in this clonal cell line may be regulated in parallel by some agents but not by others. These data also suggest that dexamethasone may decrease the biological availability of CRF in the amygdala by increasing the expression of CRF-BP, rather than by decreasing CRF expression.
authors.affiliation: Department of Psychiatry, University of Cincinnati College of Medicine, Ohio 45267, USA. mulchajj@email.uc.edu
authors.forename: J J
authors.initials: JJ
authors.lastname: Mulchahey
authors.forename: A
authors.initials: A
authors.lastname: Regmi
authors.forename: S
authors.initials: S
authors.lastname: Sheriff
authors.forename: A
authors.initials: A
authors.lastname: Balasubramaniam
authors.forename: J W
authors.initials: JW
authors.lastname: Kasckow
mesh_terms: D000679:Amygdala / Q000166:cytology / Q000187:drug effects / Q000196:embryology / Q000378:metabolism*; D000818:Animals; D002352:Carrier Proteins / Q000096:biosynthesis* / Q000235:genetics; D002461:Cell Line, Transformed; D005576:Colforsin / Q000494:pharmacology; D003346:Corticotropin-Releasing Hormone / Q000096:biosynthesis* / Q000235:genetics; D003907:Dexamethasone / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D007150:Immunohistochemistry; D015850:Interleukin-6 / Q000494:pharmacology; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects
chemical_list: D002352:Carrier Proteins; D015850:Interleukin-6; C067133:corticotropin releasing factor-binding protein; D005576:Colforsin; D003907:Dexamethasone; D003346:Corticotropin-Releasing Hormone; D013755:Tetradecanoylphorbol Acetate